HEALTH CATALYST INC - NOTE 2.500% 4/1

CUSIP: 42225TAB3

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Debt / NOTE 2.500% 4/1
Market price (% of par)
91.75%
Total 13F principal
$210,811,146
Principal change
+$838,610
Total reported market value
$211,658,136
Number of holders
21
Value change
-$1,091,314
Number of buys
11
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 42225TAB3?
CUSIP 42225TAB3 identifies 42225TAB3 - HEALTH CATALYST INC - NOTE 2.500% 4/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HEALTH CATALYST INC - NOTE 2.500% 4/1 as of Q1 2023

As of 31 Mar 2023, HEALTH CATALYST INC - NOTE 2.500% 4/1 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $210,811,146 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, LAZARD ASSET MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MARSHALL WACE, LLP, Opti Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CAPSTONE INVESTMENT ADVISORS, LLC, ADVENT CAPITAL MANAGEMENT /DE/, and WOLVERINE ASSET MANAGEMENT LLC. This page lists 21 institutional bondholders reporting positions for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.